Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sopharma AD-Sofia's Enterprise Value is лв1,283 Mil.
Sopharma AD-Sofia's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was лв104 Mil. Therefore, Sopharma AD-Sofia's EV-to-EBIT ratio for today is 12.37.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Sopharma AD-Sofia's Enterprise Value is лв1,283 Mil.
Sopharma AD-Sofia's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was лв161 Mil. Therefore, Sopharma AD-Sofia's EV-to-EBITDA ratio for today is 7.98.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Sopharma AD-Sofia's Enterprise Value is лв1,283 Mil.
Sopharma AD-Sofia's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was лв1,957 Mil. Therefore, Sopharma AD-Sofia's EV-to-Revenue ratio for today is 0.66.
Sopharma AD-Sofia Enterprise Value Historical Data
The historical data trend for Sopharma AD-Sofia's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sopharma AD-Sofia's Enterprise Value
For the Medical Distribution subindustry, Sopharma AD-Sofia's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sopharma AD-Sofia's Enterprise Value Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Sopharma AD-Sofia's Enterprise Value falls into.
Sopharma AD-Sofia Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Sopharma AD-Sofia's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sopharma AD-Sofia (XBUL:SFA) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Sopharma AD-Sofia's current Enterprise Value is лв1,283 Mil.
Sopharma AD-Sofia's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was лв104 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Sopharma AD-Sofia's current Enterprise Value is лв1,283 Mil.
Sopharma AD-Sofia's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was лв161 Mil.
Sopharma AD-Sofia's current Enterprise Value is лв1,283 Mil.
Sopharma AD-Sofia's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was лв1,957 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sopharma AD-Sofia Enterprise Value Related Terms
Thank you for viewing the detailed overview of Sopharma AD-Sofia's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products; and Others. It generates the majority of its revenue from the Distribution of pharmaceutical products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XBUL:SFA has been successfully added to your 